Chinese Journal of Organic Chemistry >
Synthesis and Biological Activity of Novel Pyrrolo[2,3-d]pyrimidine Derivatives Containing Coumarin
Received date: 2023-01-31
Revised date: 2023-03-15
Online published: 2023-05-25
Supported by
Shandong Provincial Higher Educational Science and Technology Program(J16LC52); Jinan University and the Institute Innovation Program(2020GXRC043); Young Doctor Support Program of Qilu Normal University(QBJH19-0038)
In order to search for new structural anti-tumor drugs, a series of novel pyrrolo[2,3-d]pyrimidine derivatives containing coumarin were synthesized and evaluated for their inhibitory activities against rat glioma cell (C6), human melanoma cell (A375) and oral squamous cell (FaDu) by using methyl thiazolyl tetrazolium (MTT) assay. These chemical structures were well characterized by nuclear magnetic resonance (NMR) and high-resolution mass spectra (HRMS) spectroscopic methods. 7-[7-(2-Fluorobenzyl)-5-(4-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-4-methylchromen-2-one (II1), 7-[7-(2-fluo- robenzyl)-5-(4-fluorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-4-methyl-chromen-2-one (II4), 7-[7-(3-fluorobenzyl)-5-(4- methoxy-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-4-methyl-chromen-2-one (III1), 7-[5-(4-chlorophenyl)-7-(3-fluoroben- zyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy]-4-methyl-chromen-2-one (III3) and 7-[7-(3-fluorobenzyl)-5-(4-fluorophenyl)-7H- pyrrolo[2,3-d]pyrimidin-4-yloxy]-4-methyl-chromen-2-one (III4) had better inhibitory activity against C6 cells than imatinib, compound II4 showed the most potent inhibitory activity against C6 cells with the IC50 values of 9.60 μmol/L. Compounds I2 had better inhibitory activity against FaDu cells than cisplatin, IC50 was 38.61μmol/L.
Key words： coumarin; synthesis; anticancer
Ruixia Cao , Yuping Jia . Synthesis and Biological Activity of Novel Pyrrolo[2,3-d]pyrimidine Derivatives Containing Coumarin[J]. Chinese Journal of Organic Chemistry, 2023 , 43(9) : 3304 -3311 . DOI: 10.6023/cjoc202301028
| [1] | Zhang S. Y.; Meng L.; Gao W. Y.; Song N. N.; Jia W.; Duan H. Q. China J. Chin. Mater. Med. 2005, 30, 410. (in Chinese) |
| [1] | (张韶瑜, 孟林, 高文远, 宋乃宁, 贾伟, 段宏泉, 中国中药杂志, 2005, 30, 410.) |
| [2] | Beillerot A.; Dominguez J. C.; Kirsch G.; Bagrel D. Bioorg. Med. Chem. Lett. 2008, 18, 1102. |
| [3] | Matos M.J.; Teran C.; Perez-Castillo Y.; Uriarte E.; Santana L.; Vina D. J. Med. Chem. 2011, 54, 7127. |
| [4] | Wu L.; Wang X.; Xu W.; Farzaneh F.; Xu R. Curr. Med. Chem. 2009, 16, 4236. |
| [5] | Ji H.; Tan Y. L.; Gan N. N.; Zhang J.; Li S. N.; Zheng X.; Wang Z. H.; Yi W. Bioorg. Med. Chem. 2021, 29, 115870. |
| [6] | Emami S.; Dadashpour S. Eur. J. Med. Chem. 2015, 102, 611. |
| [7] | Li Y. Y; Tang Q.; Xie Y.; He D.; Yang K.; Zheng L. F. Bioorg. Med. Chem. Lett. 2021, 33, 127750. |
| [8] | Yang K.; Li Y. Y.; Tang Q.; Zheng L. F.; He D. Eur. J. Med. Chem. 2019, 170, 45. |
| [9] | Shi L.; Li Z. Q.; Cui X. X.; Zhu T.; Pang X. J.; Li L. H.; Luo D. F.; Liu F. F.; Zhao B. Y.; Long Y.; Zhang S. Y. Chin. J. Org. Chem. 2020, 40, 1598. (in Chinese) |
| [9] | (时蕾, 李子秋, 崔鑫鑫, 朱挺, 庞晓静, 李龙辉, 罗德福, 刘方芳, 赵冰玉, 龙跃, 张赛扬, 有机化学, 2020, 40, 1598.) |
| [10] | Yuan J. L.; Shi B. Y.; Lu F.; Cao S. L. Chin. J. Synth. Chem. 2011, 19, 149. (in Chinese) |
| [10] | (袁京莉, 史博颖, 鲁丰, 曹胜利, 合成化学, 2011, 19, 149.) |
| [11] | Dang Q.; Gomez-Galeno J. E. J. Org. Chem. 2002, 67, 8703. |
| [12] | Danchev N.; Bijev A.; Yaneva D.; Vladimirova S.; Nikolova I. Arch. Pharm. Chem. Life Sci. 2006, 339, 670. |
| [13] | Gangjee A.; Jain H. D.; Kisliuk R. L. Bioorg. Med. Chem. Lett. 2005, 15, 2225. |
| [14] | Finch R. A.; Revankar G. R.; Chan P. K. Anti-Cancer Drug Des. 1997, 12, 205. |
| [15] | Mosaad S.; Mohamed R. K.; Rania H.; Abd E. Med. Chem. Res. 2013, 22, 2244. |
| [16] | Ding J.; Liu T.; Zeng C. G.; Li B. Q.; Ai Y.; Zhang X. H.; Zhong H. Chem. Heterocycl. Com. 2022, 58, 438. |
| [17] | Saito Y.; Yuki H.; Kuratani M.; Hashizume Y.; Takagi S.; Honma T.; Tanaka A.; Shirouzu M.; Mikuni J.; Handa N.; Ogahara I.; Sone A.; Najima Y.; Tomabechi Y.; Wakiyama M.; Uchida N.; Tomizawa-Murasawa M.; Kaneko A.; Tanaka S.; Suzuki N.; Kajita H.; Aoki Y.; Ohara O.; Shultz L. D.; Fukami T.; Goto T.; Taniguchi S.; Yokoyama S.; Ishikawa F. Sci. Transl. Med. 2013, 5, 181. |
| [18] | Lee J. H.; El-Damasy A. K.; Seo S. H.; Gadhe C. G.; Pae A. N.; Jeong N.; Hong S. S.; Keum G. Bioorg. Med. Chem. 2018, 26, 5596. |
| [19] | Lu L.; Guo Q. L.; Zhao L. J. Chin. Pharm. Univ. 2017, 48, 377. (in Chinese) |
| [19] | (陆璐, 郭青龙, 赵丽, 中国药科大学学报, 2017, 48, 377.) |
| [20] | Kaspersen S. J.; Han J.; N?rsett K. G.; Ryds? L.; Kj?bli E.; Bugge S.; Bj?rk?y G.; Sundby E.; Hoff B. H. Eur. J. Pharm. Sci. 2014, 59, 69. |
| [21] | Musumeci F.; Fallacara A. L.; Brullo C.; Grossi G.; Botta L.; Calandro P.; Chiariello M.; Kissova M.; Crespan E.; Maga G.; Schenone S. Eur. J. Med. Chem. 2017, 127, 369. |
| [22] | Pudlo J. S.; Nassiri M. R.; Kern E. R.; Wotring L. L.; Drach J. C.; Townsend L. B. J. Med. Chem. 1990, 33, 1984. |
| [23] | Xing Q. Y.; Pei W. W.; Xu R. Q.; Pei J. Basic Organic Chemistry, Higher Education Press, Beijing, 2016, pp. 912-913. (in Chinese) |
| [23] | (邢其毅, 裴伟伟, 徐瑞秋, 裴坚, 基础有机化学, 高等教育出版社, 北京, 2016, pp. 912-913.) |
| [24] | Situ Z. Q.; Wu J. Z. Cell Culture, World Book Inc., Xi'an, 2004, pp. 250-252. (in Chinese) |
| [24] | (司徒镇强, 吴军正, 细胞培养, 世界图书出版社, 西安, 2004, pp. 250-252.) |
/
| 〈 |
|
〉 |
